about
Prevalence of the prescription of potentially interacting drugsLower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort studyAre generic and brand-name statins clinically equivalent? Evidence from a real data-base.Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].Adherence to lipid-lowering treatment: the patient perspective.Statin use and risk of new-onset diabetes: A meta-analysis of observational studies.C-reactive protein distribution and correlation with traditional cardiovascular risk factors in the Italian population.PCSK9 inhibition in statin-intolerant HeFH patients: What's new?A simple informative intervention in primary care increases statin adherence.Drug treatment and adherence of subjects <40 years with diagnosis of heterozygous familial hypercholesterolemia.Statin use and risk of cataract: A nested case-control study within a healthcare database.Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.Statins and the risk of diabetes: evidence from a large population-based cohort study.Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population.Detection of familial hypercholesterolemia in patients from a general practice database.Tools to investigate and avoid drug-hypersensitivity in drug development.Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps.Reaching LDL-c targets in high-risk patients requires high-efficacy cholesterol-lowering drugs in more than 50% of cases. The results of the CHECK study.Corrigendum to "Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database" [Diabetes Res. Clin. Pract. 108 (2) (2015) 243-249].Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN).Reply to: "Statins probably do not cause cataracts".High-potency statins increase the risk of acute kidney injury: Evidence from a large population-based studyLipid Lowering and Incidence of Cataract, a Role for FibratesEpidemiology of cardiovascular risk factors in two population-based studiesUse of proton pump inhibitors and risk of ischemic events in the general populationCardiovascular events with PCSK9 inhibitors: an updated meta-analysis of randomised controlled trials
P50
Q28534352-7128536D-5D15-4921-BEE6-C3FC065388C4Q28534935-DA03C5C0-22A0-44FC-89D6-83BF3E5803F8Q30848664-FFB747FB-3ECC-46D2-AE1C-16FF55C3BEAEQ34365060-5EDCF524-618E-461C-8C4E-A797AE47CC5DQ36394334-989D6DED-A8EE-40CA-85E9-B5E3775BEF96Q38833866-608815E4-AE34-4F8E-9DB0-0EC590B76B6FQ39541315-5942182D-EAAA-4976-906F-01880D4EA7A3Q40114602-FB2B69D7-38E5-49B1-BB31-8ADA8714A823Q40327063-204F5BF7-3437-4490-B4C3-FEFCE0F5C9E2Q40537893-E4ECD7E0-692B-423E-B5D9-AB5AEBB93D74Q40691564-66D6D374-0671-4930-A293-562AABAE62FDQ41274092-84DA9D1C-57EB-4153-A3A4-A61FD46CF143Q43884432-602DA815-1617-4C78-B54C-E4021CC03626Q45356825-0524D7CD-C28E-4515-B0D3-DE56C145AC7EQ47890697-70880ED3-E942-4A1C-BEAB-B6305181A01EQ48100608-46BE7B50-1B44-444E-8395-B1DBE9997C07Q50084252-E0DF555C-4237-4FBF-A330-D5F932F6EB8DQ53150161-0C9B6427-6F0A-43CD-9254-49E3961F7A63Q53763528-3EE3AF74-D20F-4EFD-BD39-011789D5063CQ54215101-B099DA60-506E-4300-8E56-D7F32CEFA4FAQ54680582-110F6685-D89B-4DC2-91F1-4765CB6CD799Q62024153-B556AB8C-8D6E-472F-8462-E4E47B28C11CQ90296011-A69307C1-A104-4275-A256-FB22F01F7DF6Q91275283-2F14FD11-34ED-4E53-A0C3-9C590ED86310Q91429212-BCCD5C55-3A87-4B5A-B649-A50B7D0241D6Q92706587-72614F8A-DC3C-4266-B22A-2EB900957902
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manuela Casula
@ast
Manuela Casula
@en
Manuela Casula
@es
Manuela Casula
@nl
Manuela Casula
@sl
type
label
Manuela Casula
@ast
Manuela Casula
@en
Manuela Casula
@es
Manuela Casula
@nl
Manuela Casula
@sl
prefLabel
Manuela Casula
@ast
Manuela Casula
@en
Manuela Casula
@es
Manuela Casula
@nl
Manuela Casula
@sl
P106
P21
P31
P496
0000-0002-5124-5361